Hepion Pharmaceuticals (NASDAQ: HEPA) director purchases 2M shares and 2M warrants
Rhea-AI Filing Summary
Hepion Pharmaceuticals director Michael J. Purcell reported significant insider purchases. On 2026-08-03, he bought 2,000,000 shares of common stock at $0.05 per share, increasing his direct common stock holdings to 3,250,000 shares. He also purchased 2,000,000 warrants with an exercise price of $0.06 per share, exercisable into 2,000,000 common shares and expiring on 2031-08-03, leaving him holding 2,000,000 warrants after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,000,000 shares
Net Buy
2 txns
Insider
Purcell Michael J.
Role
Director
Bought
4,000,000 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrants | 2,000,000 | $0.00 | $0.00 |
| Purchase | Common Stock | 2,000,000 | $0.05 | $100K |
Holdings After Transaction:
Warrants — 2,000,000 shares (Direct);
Common Stock — 3,250,000 shares (Direct)
Key Figures
Common shares purchased: 2,000,000 shares
Purchase price per common share: $0.05
Common shares held after transaction: 3,250,000 shares
+3 more
6 metrics
Common shares purchased
2,000,000 shares
Common stock bought on 2026-08-03 at $0.05 per share
Purchase price per common share
$0.05
Price for 2,000,000 common shares acquired on 2026-08-03
Common shares held after transaction
3,250,000 shares
Direct Hepion common stock position after the 2026-08-03 purchase
Warrants purchased
2,000,000 warrants
Derivative securities acquired on 2026-08-03
Warrant exercise price
$0.06 per share
Conversion or exercise price for 2,000,000 warrants into common stock
Warrant expiration date
2031-08-03
Expiration of 2,000,000 warrants acquired on 2026-08-03
Key Terms
Warrants, Exercise price, Expiration date
3 terms
Warrants financial
"security_title: Warrants with an exercise price of $0.06 per share"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Exercise price financial
"conversion_or_exercise_price: 0.0600 indicates the exercise price of the warrants"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Expiration date financial
"expiration_date: 2031-08-03 specifies the warrants' expiration date"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transactions did HEPA director Michael J. Purcell report?
Michael J. Purcell reported two purchases on 2026-08-03: 2,000,000 common shares at $0.05 per share and 2,000,000 warrants with a $0.06 exercise price expiring in 2031.
What warrants did the HEPA director acquire in this Form 4 filing?
Michael J. Purcell acquired 2,000,000 warrants on 2026-08-03. Each warrant has an exercise price of $0.06 per share, is exercisable for one share of common stock, and expires on 2031-08-03.
Were the HEPA insider transactions in this Form 4 part of a Rule 10b5-1 plan?
The filing indicates the Rule 10b5-1 checkbox is not affirmed (set to false), meaning these reported purchases are not identified as being made under a Rule 10b5-1 trading plan.
What were the purchase prices in the HEPA Form 4 transactions?
The common stock was purchased at $0.05 per share. The warrants were acquired with an exercise price of $0.06 per share, and the transaction price for the warrants is reported as $0.00 per warrant in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
